Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 1,321–1,328 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Cognition Therapeutics Inc. CT1812 - (SEQUEL) Mild-to-Moderate Alzheimer's Disease Phase 2 Trial Completed Oral Neurology
Cognition Therapeutics Inc. CT1812 - (SNAP) Alzheimer's Disease Phase 2 Trial Completed oral Neurology
Cognition Therapeutics Inc. Zervimesine (CT1812) - (START) Mild Alzheimer's disease Phase 2 Enrollment Initiation oral Neurology
Cognition Therapeutics Inc. Zervimesine (CT1812) - (SHINE) Mild-to-Moderate Alzheimer's Disease Phase 3 Trial Planned Oral Neurology
Cognition Therapeutics Inc. Zervimesine (CT1812) - (SHIMMER) Dementia with Lewy Bodies (DLB) Phase 2 Enrollment Conclusion oral Neurology
Coherus Oncology Inc. Toripalimab - (JUPITER-06) Esophageal Squamous Cell Carcinoma BLA Filing Intravenous Oncology
Coherus Oncology Inc. Toripalimab - (JUPITER-08) Extensive stage SCLC Phase 3 Intravenous Oncology
Coherus Oncology Inc. Toripalimab + platinum-doublet chemotherapy - (NEOTORCH) NSCLC neoadjuvant setting Phase 3 Intravenous Oncology